Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on March 29, 2022. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report primarily addresses a Regulation FD disclosure regarding a new strategic partnership.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. This document serves as a disclosure of a corporate event rather than a financial performance report.
Material Changes
The material change disclosed is the execution of a new partnership agreement with Summit Blue Capital. This agreement is designed to implement a leasing and finance program specifically for the Company's PURE EP™ System.
Guidance, Outlook, and Risks
- Management Commentary: The Company issued a press release (Exhibit 99.1) detailing the partnership but explicitly undertakes no obligation to update, supplement, or amend the materials attached.
- Regulatory Status: The information provided under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
- Materiality: The Company states that furnishing this information is not intended to constitute a determination that the information is material or that dissemination is required under Regulation FD.
Investor Verification Checklist
- Verify the specific terms and financial impact of the partnership with Summit Blue Capital by reviewing Exhibit 99.1 (Press Release).
- Confirm the operational status and market adoption of the PURE EP™ System to assess the potential revenue impact of the new leasing program.
- Review subsequent filings to determine if the Company updates the status of this partnership, as no obligation to update was stated in this report.
- Check the Company's latest 10-K or 10-Q for actual financial metrics, as this 8-K contains no quantitative financial data.